Cannabinoids Alleviate Experimentally Induced Intestinal Inflammation by Acting at Central and Peripheral Receptors

• Jakub Fichna,

  Affiliations Snyder Institute for Chronic Disease, Department of Medicine, University of Calgary, Calgary, Alberta, Canada, Department of Biochemistry, Medical University of Lodz, Lodz, Poland

  ⨯
• Misha Bawa,

  Affiliation Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Ganesh A. Thakur,

  Affiliation Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America

  ⨯
• Ritesh Tichkule,

  Affiliation Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America

  ⨯
• Alexandros Makriyannis,

  Affiliation Center for Drug Discovery, Department of Pharmaceutical Sciences, Northeastern University, Boston, Massachusetts, United States of America

  ⨯
• Donna-Marie McCafferty,

  Affiliation Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Keith A. Sharkey,

  Affiliations Snyder Institute for Chronic Disease, Department of Medicine, University of Calgary, Calgary, Alberta, Canada, Department of Physiology and Pharmacology, University of Calgary, Calgary, Alberta, Canada, Hotchkiss Brain Institute, University of Calgary, Calgary, Alberta, Canada

  ⨯
• Martin Storr

  * E-mail: Martin.Storr@med.uni-muenchen.de

  Affiliations Snyder Institute for Chronic Disease, Department of Medicine, University of Calgary, Calgary, Alberta, Canada, Division of Gastroenterology, Department of Medicine, University of Munich, Munich, Germany

  ⨯